4D Path Series A

4D Path has created the QPOR™ Platform, a groundbreaking solution designed to directly measure and quantify cell cycle deregulations and tumor microenvironment dynamics. This platform precisely predicts a patient's response to therapy, enabling researchers and clinicians to understand which treatment most effectively targets a patient's specific tumor. 4D Path partners with others to deliver customized treatment prediction signatures for therapies, aiming to provide a true treatment match for cancer patients.